Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2018 Mar 1;35(1):92-93.
doi: 10.4274/tjh.2017.0283. Epub 2018 Feb 2.

Expansion of a Myeloma-associated Lesion from Orbita to the Cerebrum

Sinan Demircioğlu  1 , Demet Aydoğdu  2 , Özcan Çeneli  1
Affiliations
Case Reports

Expansion of a Myeloma-associated Lesion from Orbita to the Cerebrum

Sinan Demircioğlu et al. Turk J Haematol. .
No abstract available

Keywords: Multiple myeloma; Orbita Cerebrum..

PubMed Disclaimer

Conflict of interest statement

Conflict of Interest: The authors of this paper have no conflicts of interest, including specific financial interests, relationships, and/or affiliations relevant to the subject matter or materials included.

Figures

Figure 1
Figure 1. Cranial axial contrast magnetic resonance image before treatment: in the lateral aspect of the right orbit there is a mass lesion that expands and destroys the zygomatic bone and temporal lobe (red arrow). The mass lengthened in the cerebral parenchyma by invading the dura in the temporal region.
Figure 2
Figure 2. There is widespread edema (T2 axial images) around the joint due to cerebral parenchymal involvement.
Figure 3
Figure 3. Significant regression is seen in the lesion after treatment (red arrow).
See this image and copyright information in PMC

References

    1. Fassas AB, Muwalla F, Berryman T, Benramdane R, Joseph L, Anaissie E, Sethi R, Desikan R, Siegel D, Badros A, Toor A, Zangari M, Morris C, Angtuaco E, Mathew S, Wilson C, Hough A, Harik S, Barlogie B, Tricot G. Myeloma of the central nervous system: association with high-risk chromosomal abnormalities, plasmablastic morphology and extramedullary manifestations. Br J Haematol. 2002;117:103–108. - PubMed
    1. Nieuwenhuizen L, Biesma DH. Central nervous system myelomatosis: review of the literature. Eur J Haematol. 2008;80:1–9. - PubMed
    1. Gangatharan SA, Carney DA, Prince HM, Wolf MM, Januszewicz EH, Ritchie DS, Harrison SJ. Emergence of central nervous system myeloma in the era of novel agents. Hematol Oncol. 2012;30:170–174. - PubMed
    1. Gozzetti A, Cerase A, Lotti F, Rossi D, Palumbo A, Petrucci MT, Patriarca F, Nozzoli C, Cavo M, Offidani M, Floridia M, Berretta S, Vallone R, Musto P, Lauria F GIMEMA (Gruppo Italiano Malattie Ematologiche dell’Adulto) Myeloma Working Party, Marchini E, Fabbri A, Oliva S, Zamagni E, Sapienza FG, Ballanti S, Mele G, Galli M, Pirrotta MT, Di Raimondo F. Extramedullary intracranial localization of multiple myeloma and treatment with novel agents: a retrospective survey of 50 patients. Cancer. 2012;118:1574–1584. - PubMed
    1. Petersen SL, Wagner A, Gimsing P. Cerebral and meningeal multiple myeloma after autologous stem cell transplantation. A case report and review of the literature. Am J Hematol. 1999;62:228–233. - PubMed

Substances